Concepedia

Luxin Sun

LS

Statistics

Publications

10

Citations

263

H-Index

10

Active since

2013

Affiliations

Moffitt Cancer Center(Current)

University of Alberta

University of Minnesota

Luxin Sun is an author at Moffitt Cancer Center specializing in life sciences, drug discovery, and drug design.

ORCID

Publications per year

2013–2024

10

Publications

10

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

Erik B. Faber, Luxin Sun, Jian Tang et al. · Nature Communications · 2023 · 48 citations · Full text

, , +14

Peptide Library Approach to Uncover Phosphomimetic Inhibitors of the BRCA1 C-Terminal Domain

E. Railey White, Luxin Sun, Zhong Ma et al. · ACS Chemical Biology · 2015 · 41 citations · Full text

, , +16

Antitumor Activity of Lankacidin Group Antibiotics Is Due to Microtubule Stabilization via a Paclitaxel-like Mechanism

Ahmed T. Ayoub, Rabab M Abou El-Magd, Jack Xiao et al. · Journal of Medicinal Chemistry · 2016 · 32 citations · Full text

, , +17

Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice

Erik B. Faber, Nan Wang, Kristen John et al. · Journal of Medicinal Chemistry · 2023 · 32 citations · Full text

, , +12

Structural Insights into Recognition of MDC1 by TopBP1 in DNA Replication Checkpoint Control

Charles Chung Yun Leung, Luxin Sun, Zihua Gong et al. · Structure · 2013 · 31 citations · Full text

, , +12

1–5 of 10